Annual Report 2001 - Cornell University
006 Transferring Technology

01 Aegen Biosciences, Inc.

Aegen Biosciences, Inc., a small biotechnology company in Monterey, CA, uses Cornell University discoveries to develop next-generation analytical tools for toxicology, drug discovery, drug development, pharmacogenomics, and clinical diagnostics. Aegen is developing an animal-on-a-chip device based on technology invented at Cornell by Michael L. Shuler, Chemical Engineering, and Gregory T. Baxter, formerly senior research associate, now president/CEO of Aegen. Commercialization of the technology has the potential to increase the success rates and decrease the development time of marketable drugs, while greatly reducing the number of animals used during preclinical studies.

> Back  /  > Next Article  /  > Back to Listing

© 2002 by the Office of the Vice Provost for Research [OVPR], Cornell University.

Cornell University  
314 Day Hall
Ithaca, New York

P: 607.255.7200
F: 607.255.9030
E: VP Research
C: Credits